Thirdly, overexpression of EVI1 was reported to augment sensitivity towards arsenic trioxide in in vitro models of myeloid malignancies and in patients with myelodysplastic syndrome [40]. This evidence concerns the gene MECOM and myelodysplastic syndrome.